why choose us

First received: September 13, 2023

Clinical Trial: IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Randomized Withdrawal and Retreatment Phase III Clinical Trial Evaluating the Efficacy and Safety of Subcutaneous Injection of IBI112 in th

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and tolerability of IBI112 in the treatment of participants with moderate to severe psoriasis

Read more